Tabada, Romelia .
HRN: 01-71-11 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/03/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/03/2024
09/09/2024
IV
500mg
Q8
Intrabdominal Infection
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes